Konstantinos Tziomalos, Vasilios Giampatzis, Stella D. Bouziana, Marianna Spanou, Stavroula Kostaki, Maria Papadopoulou, Stella-Maria Angelopoulou, Filitsa Konstantara, Christos Savopoulos, Apostolos I. Hatzitolios
Category Archives: Volume 6 – Issue 2
Clopidogrel binds to lp-pla2 and inhibits the enzyme activity. A new pleiotropic effect of this antiplatelet drug?
M.E. Tsoumani, C.C. Tellis, M.V. Chatziathanasiadou, A.N. Katsikoudi, V.G. Kontogianni, A.G. Tzakos, A.D. Tselepis
The role of PCSK9 protein in lipoprotein (a) metabolism
E. Klouras, M. Elisaf
The composite role of PCSK9 protein
E. Klouras, M. Elisaf
SGLT2 inhibitors: what to expect in the future
Α. Liontos, E. Klouras, M. Florentin, E. Liberopoulos, M. Elisaf
The use of dapagliflozin in the treatment of type 2 diabetes mellitus
Α. Liontos, E. Klouras, M. Florentin, E. Liberopoulos, M. Elisaf
Non-alcoholic fatty liver disease in HIV-infected patients without viral hepatitis. What can we do about their cardiovascular risk?
Georgios Sfikas, Chrysoula Boutari, Konstandinos Tassios, Konstantinos Kaitanidis, Eydoxia Mitsiou, Vasilios G. Athyros
Metabolic syndrome, Barrett’s oesophagus, the risk of oesophageal adenocarcinoma, and statin treatment
Chrysoula Boutari, Stella-Maria Angelopoulou, Georgios Sfikas, Konstantinos Kaitanidis, Konstantinos Tziomalos, Vasilios G. Athyros
Intensive glucose control in patients with type 2 diabetes mellitus and incidence of cardiovascular events. Has this issue been resolved?
K. Kaitanidis, C. Boutari, A. Lazaridis, M. Doumas, K. Tziomalos, V.G. Athyros